Global Tumor Targeted Drug Detection Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Tumor Targeted Drug Detection Kit market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

This kit is an in vitro diagnostic reagent based on second-generation sequencing technology. Detection of common driver gene mutations in non-small cell lung cancer (EGFR, ALK, ROS1, BRAF, RET, ERBB2, NTRK, KRAS, etc.) and immunotherapy positive/negative/hyper-progression related genes. The types of mutations detected include point mutations, Insertions, deletions, rearrangements, fusions. The applicable sample type is paraffin-embedded tissue sample (FFPE).

This report is a detailed and comprehensive analysis for global Tumor Targeted Drug Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Tumor Targeted Drug Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tumor Targeted Drug Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tumor Targeted Drug Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tumor Targeted Drug Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Tumor Targeted Drug Detection Kit

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Tumor Targeted Drug Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BGI, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Tumor Targeted Drug Detection Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Single Gene Testing
Multigene Testing

Market segment by Application
Online Sales
Offline Sales

Major players covered
BGI
Quest Diagnostics
Gene By Gene（myDNA Inc.）
DNA Diagnostics Center
Invitae
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Tumor Targeted Drug Detection Kit product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Tumor Targeted Drug Detection Kit, with price, sales quantity, revenue, and global market share of Tumor Targeted Drug Detection Kit from 2020 to 2025.

Chapter 3, the Tumor Targeted Drug Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Tumor Targeted Drug Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tumor Targeted Drug Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Tumor Targeted Drug Detection Kit.

Chapter 14 and 15, to describe Tumor Targeted Drug Detection Kit sales channel, distributors, customers, research findings and conclusion.